Amgen’s IMDYLLTRA Wins EU Approval for Small Cell Lung Cancer
THOUSAND OAKS, Calif., June 1, 2026 Amgen has secured a major regulatory milestone with the European Commission approval of...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
THOUSAND OAKS, Calif., June 1, 2026 Amgen has secured a major regulatory milestone with the European Commission approval of...
MOUNTAIN VIEW, Calif., May 29, 2026 NeuroPace, Inc., a leading medical technology company focused on transforming the treatment of...
VANCOUVER, British Columbia, May 29, 2026 Optimi Health Corp. has welcomed new recommendations issued by Australia’s Therapeutic Goods Administration...
MONTREAL, Canada, May 29, 2026 Leica Biosystems, a global leader in anatomic and digital pathology solutions, and CellCarta, a...
CHICAGO, Ill., May 29, 2026 Cardiosense has achieved a major regulatory milestone with the U.S. Food and Drug Administration...
LONDON, UK, May 28, 2026 GSK has announced groundbreaking Phase III clinical trial results for bepirovirsen, its investigational antisense...
SEATTLE and SINGAPORE, May 27, 2026 Callio Therapeutics has announced the presentation of its Phase 1 clinical trial design...
BASEL, Switzerland, May 27, 2026 Roche has announced the launch of its groundbreaking Liver Disease Panel, the healthcare industry’s...
WALTHAM, Massachusetts, May 26, 2026 Mercy BioAnalytics, Inc. has announced that it will present new clinical data at the...
BOSTON, Massachusetts, May 26, 2026 Ginkgo Bioworks, through its Ginkgo Datapoints platform, has announced the launch of ADME-Oneâ„¢, a...
